Track Changchun BCHT Biotechnology's receivables ($870M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Changchun BCHT Biotechnology (688276.SS) currently reports a receivables of $870M as of June 2026. That compares with $1.2B in the prior-year period — down 25.9% year over year. Use the charts on this page to explore Changchun BCHT Biotechnology's receivables history and peer comparisons.
Changchun BCHT Biotechnology's receivables decreased from $1.2B to $870M — a 25.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Changchun BCHT Biotechnology reported $870M in receivables as of June 2026. That compares with $1.2B in the prior-year period — down 25.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $870M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Changchun BCHT Biotechnology, and consider following 688276.SS for alerts when major investors trade the stock.